Breaks Categories: News

ThursdayAug 10, 2017 9:49 am

NetworkNewsBreaks – Data and Safety Monitoring Board Recommends Completion of ARCA biopharma, Inc.’s (NASDAQ: ABIO) GENETIC-AF Trial

ARCA biopharma (NASDAQ: ABIO) this morning said the GENETIC-AF trial Data and Safety Monitoring Board (DSMB) has completed its pre-specified phase 2B interim analysis and has recommended completion of the study with no changes to the trial design. GENETIC-AF is a clinical trial evaluating Gencaro™ as a candidate for the treatment of atrial fibrillation (AF). The Gencaro development program has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). “The DSMB stated that there were no safety concerns and that the efficacy results met the prespecified criteria for continuing the Phase 2B trial to completion. We…

Continue Reading

ThursdayAug 10, 2017 9:32 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Discusses Company’s Progress in Interview

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced that its chief executive officer, Chris Bunka, was featured in a recent interview on the Uptick Network Stock Day Radio Show. Bunka leveraged the platform to discuss Lexaria’s overall accomplishments in the past three months, as well as the company’s expectations for profitability moving forward. He notes that ongoing research and development programs could open both the NSAID and Nicotine markets to Lexaria, providing an opportunity to significantly increase corporate revenues and facilitate further expansion. “In the…

Continue Reading

WednesdayAug 09, 2017 12:40 pm

NetworkNewsBreaks – IPO Complete, China Internet Nationwide Financial Services, Inc. (NASDAQ: CIFS) Focuses on Providing Financial Solutions to Target Market in China

China Internet Nationwide Financial Services (NASDAQ: CIFS), on its second day as a NASDAQ-listed company, is trading at $11.93 on volume of just over 70,000. The provider of financial advisory services to the underserved small-to-medium sized enterprises in China yesterday ended its first day of trading up 23% at $12.30 per share. Boustead Securities, LLC served as the company’s lead underwriter and completed its IPO of 2,023,146 of CIFS’s ordinary shares priced at $10 per share for a total of $20,231,460 before underwriting discounts, commissions and offering expenses. "We are honored and humbled to become an official member of the…

Continue Reading

WednesdayAug 09, 2017 12:34 pm

NetworkNewsBreaks – Amyris, Inc. (NASDAQ: AMRS) Close $50M in Second Tranche Equity Financing; Shares Fall

Amyris (NASDAQ: AMRS) is trading at a new 52-week low of $2.54, down more than 8% after reporting the close of the second and final tranche of its previously announced financing. The second tranche of a private placement resulted in a total of $50 million, comprised of a $25-million investment from Koninklijke DSM N.V. and $25 million contributed by Vivo Capital. “We’ve delivered a very strong first half and are on track for our best year ever with more than doubling our product sales and continuing to build on our collaboration agreements while reducing our losses. As a result, later…

Continue Reading

WednesdayAug 09, 2017 12:30 pm

NetworkNewsBreaks – Moleculin Biotech, Inc.’s (NASDAQ: MBRX) CEO Shares Opinion on Recent FDA Drug Approvals for Acute Myeloid Leukemia

Shares of Moleculin Biotech (NASDAQ: MBRX) are up 9% mid-day following the company’s comments regarding the recent FDA approvals for new drugs for the treatment of acute myeloid leukemia (AML). The company’s drug candidate, Annamycin, is currently being evaluated for the treatment of relapsed or refractory AML. “While these new drugs make valuable incremental improvements in AML therapy, most AML patients will still fail to respond to (or relapse from) initial therapy; therefore, our initial clinical development plan will attempt to address the significant unmet need of patients who relapse from, or are refractory to, initial therapy. We also believe…

Continue Reading

WednesdayAug 09, 2017 9:04 am

NetworkNewsBreaks – Patriot One Technologies’ (TSX.V: PAT) (OTCQB: PTOTF) PATSCAN CMR Attains Milestone in Certification Pathway

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) this morning announced that its award-winning PATSCAN CMR™ (Cognitive Microwave Radar) concealed weapons detection system has met Federal Communications Commission (FCC) and Industry Canada (IC) regulatory requirements, as verified through a series of tests by an accredited third party laboratory. “This is significant news for our Company,” Dinesh Kandanchatha, CTO of Patriot One Technologies, stated in the news release. “Many companies have found meeting FCC and IC requirements to be a daunting challenge. Since we began operations last November we have worked relentlessly to identify, execute and address a lengthy checklist of…

Continue Reading

TuesdayAug 08, 2017 12:40 pm

NetworkNewsBreaks – Rennova Health, Inc. (NASDAQ: RNVA) Opens Big South Fork Medical Center

Rennova Health (NASDAQ: RNVA) (NASDAQ: RNVAZ) this morning said it has opened the Big South Fork Medical Center (BSFMC) and provision of 24/7 services. Located in Oneida, Tennessee, the hospital offers in-patient and outpatient services including a 24/7 emergency department. Future plans for the hospital include submitting an application to be classified as a Critical Access Hospital which will in turn enable certain advantages with payers. "We believe our investment and ability to facilitate the needs of doctors and other healthcare providers in the local area will enable us to exceed previous revenues achieved by this hospital. This opening is…

Continue Reading

TuesdayAug 08, 2017 12:37 pm

NetworkNewsBreaks – Cellectar Biosciences, Inc. (NASDAQ: CLRB) Trading Volume Surges on Positive CLR 131 Report

Shares of Cellectar Biosciences (NASDAQ: CLRB) are up 9%, continuing a pre-market surge and moving on volume of 4.8 million, compared to the 30-day average of 86,851, after the company said that CLR 131 has achieved a median overall survival of 22.5 months to date in patients with multiple myeloma. The company’s ongoing phase 1 clinical trial surpasses historic published outcomes of currently marketed second and third line treatment modalities for multiple myeloma and could continue to increase over time. “We continue to make meaningful progress on our CLR 131 program and are encouraged by the observed clinical outcomes to…

Continue Reading

TuesdayAug 08, 2017 9:37 am

NetworkNewsBreaks – ORHub, Inc. (ORHB) Primed to Expand Medical Software into Major US Markets following Agreement with National Sales Partner

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) this morning announced its agreement with a national sales and business development partner with specialized capabilities in health care solutions delivery. With this agreement, ORHub’s reach will now extend into executive suites with hospitals and hospital systems across 11 major U.S. metropolitan markets. “This sales partner contract gives ORHub immediate scale and reach into a national sales infrastructure,” Colt Melby, CEO of ORHub, stated in the news release. “It allows us to focus on our software and analytics platform and help hospitals and surgeons make real-time, data-driven decisions that improve business profitability…

Continue Reading

TuesdayAug 08, 2017 9:07 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Acquires $Weed Cryptocurrency

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its purchase of the $Weed cryptocurrency from joint venture partner First Bitcoin Capital (OTC: BITCF). Aimed at solving the payment problems that currently exist in the cannabis industry, WeedCoin is already listed on three exchanges, and SinglePoint intends to list and market the currency on more exchanges moving forward. Additionally, the company plans to invest heavily in attracting customers to sign up for a $Weed wallet before visiting the dispensary. If successful, these efforts will address one of the largest barriers relating to the use of cryptocurrency at cannabis retail…

Continue Reading